While several molecular markers for the development, recurrence and progression of bladder cancer, such as p53 and Rb, have been studied [1-3], the limited value of these established prognostic markers created the need for new molecular indicators of bladder cancer outcomes. This evidence concerns the gene RB1 and urinary bladder carcinoma.